various disease states,0.446579
email newsletter,0.560435
52-week low,-0.718078
stage biopharmaceutical company,0.320911
52-week high,-0.718078
email address,0.448938
related companies,0.560435
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.433902
high fees,-0.735674
Zacks Investment Research,0.40995
personal trading style,0.598412
latest news,0.448938
target price,0.237093
Roth Capital,0.237093
Rexahn Pharmaceuticals Inc.,0.560435
buy rating,0.237093
research note,0.237093
sexual dysfunction,-0.296807
research offerings,0.40995
proprietary technology platform,0.546893
unmet medical needs,-0.296807
concise daily summary,0.448938
Rexahn Pharmaceuticals,-0.344237
REXAHN PHARMACTICALS,0.546893
stock broker,0.245696
clinical stage,0.320911
